Antibiotics: Novel business models neededAntibiotic resistance is widespread. Its global human and economic burden is tremendous and constantly increasing. Despite the recognised and growing need for new antibiotics, most large pharmaceutical … more ➔
Nagoya protecting resources with paperw...European Biotechnology Network had the good fortune to moderate the 8th Berlin Conference on IP in Life Science, which this year had a focus on natural products. That will be interesting, I thought … more ➔
Expert opinion: Dont cross the RubiconModern biotechnology has already helped many patients and we need to continue research and development because many diseases cannot be cured yet. However, inappropriate use of technology has serious … more ➔
Dont misinterpret the results of the ref...During the Swiss Biotech Day in Zurich, the Swiss Biotech Report 2014 highlighted the most important innovation drivers in the countrys industry and summarised the sectors most relevant topics. more ➔
Europe triumphs at kicking the GM ball int...You would have to be blind, deaf and living in a hole for the last twenty years to not know that Europe struggles with the whole GMO thing. more ➔
Growing potential for cancer immunotherapyImmune therapies have rapidly gained the attention of the medical community as a new hope for cancer treatment. Arguably, the intersection of immunology and oncology represents one of the most promising … more ➔
Dear Carlos We have a new set of European Commissioners, and I thought that in this issue, it would be very nice to have a look at one of them through the lens of biotechnology. Commissioner for Research, Science … more ➔
Manufacturing process validation what...In the last few years, the regulatory landscape overseeing manufacturing process validation has faced major overhauls in two ICH (International Conference on Harmonisation of Technical Requirements for … more ➔
Once upon a time a story for SMEsThis summer saw the first deadline for the new SME Instrument, and the evaluation feedback from the European Commission could be a wake-up call for small companies across Europe. more ➔
Licensing a matter of external innovati...External innovation is one of the pharmaceutical industrys solutions for overcoming patent cliffs and gaps in innovation. Its based on the insight that the majority of innovations in this sector … more ➔
